programma definitivo - SocietÃ italiana di neurologia

More documents

Recommendations

Info

3 N O V E M B R E • A R E A P O S T E R 119. INFLUENCE OF DIABETES ON THE OUTCOME OF HOSPITALIZED STROKE PATIENTS R. ORNELLO, S. RICCI, M. ROSSI, S. SACCO, A. CAROLEI (L’Aquila) 120. VARICELLA ZOSTER VASCULOPATHY: AN UNDERDIAGNOSTICATED CAUSE OF STROKE IN YOUNG ADULTS V. PIRAS, P. MARCHI, J. MOLLER, L. PINNA, M. MELIS (Cagliari) 121. PROGNOSTIC VALUE OF MIDDLE CEREBRAL ARTERY HYPERDENSITY AND EARLY ISCHEMIC CHANGES IN ACUTE ISCHEMIC STROKE TREATED WITH THROMBOLYSIS. ANALYSIS OF A COHORT OF PATIENTS FROM THE SYNTHESIS EXPANSION TRIAL C. MOTTO, S. LANFRANCONI, P. BASILICO, P. DONEDA, M. CAVAZZUTI, F. MUSCIA, M. GAMBA, D. RIZZI, C. AZZINI, M. CHINAGLIA, P. NENCINI, E. VERRENGIA, E. AGOSTONI, M. RUSSO, A. CICCONE FOR THE SYNTHESIS EXPANSION INVESTIGATORS (Milano, Modena, Como, Brescia, Genova, Ferrara, Rovigo, Firenze, Varese, Mantova) 122. CLINICAL CHARACTERISTICS AND EARLY OUTCOME OF ISCHEMIC STROKE IN THE OLDEST OLD C. DI CARMINE, C. TISEO, M. MANTENUTO, A. CAROLEI, S. SIMONA (L’Aquila) 123. QUALITY OF CARE REGISTRY OF CEREBROVASCULAR DISEASE IN THE VENETO REGION: ONE YEAR OF EXPERIENCE IN MONITORING AND IMPLEMENTING STROKE CARE L. NARDETTO, M. SAUGO, S. TONELLO, F. AVOSSA, M. LISIERO, M. PIGATO, M. SAIA, B. GIOMETTO (Treviso, Padova, Venezia) 124. FIBRINOGEN DEPLETION AFTER I.V. THROMBOLYSIS M. VEDOVELLO, T. PARTZIGUIAN, M. ROTTOLI, V. BONITO, M. SGARZI, R. RIVA, D. ALIMONTI, E. AGAZZI, M. ROSSI, P. FILISETTI, E. ROTTOLI, O. VALOTI, M. POLONI, B. CENSORI (Bergamo) 125. IMMUNE-INFLAMMATORY MARKERS AND ARTERIAL STIFFNESS INDEXES IN SUBJECTS WITH ACUTE ISCHEMIC STROKE WITH AND WITHOUT METABOLIC SYNDROME A. TUTTOLOMONDO, R. PECORARO, D. DI RAIMONDO, R. DI SCIACCA, G. LICATA, A. PINTO (Palermo) 126. ARTERIAL STIFFNESS AND ISCHEMIC STROKE IN SUBJECTS WITH AND WITHOUT METABOLIC SYNDROME A. TUTTOLOMONDO, R. PECORARO, D. DI RAIMONDO, R. DI SCIACCA, G. LICATA, A. PINTO (Palermo) 127. ACUTE ISCHAEMIC STROKE: USE OF MR IN THE REAL WORLD R. CONDURSO, S. CENCIARELLI, E. GALLINELLA, A. MATTIONI, I. SICILIA, C. PADIGLIONI, T. MAZZOLI, L. GRECO, S. RICCI (Città <strong>di</strong> Castello - PG, Branca - PG) 128. TIME IS BRAIN: THE IMPORTANCE OF THE NETWORK INSIDE AND OUTSIDE THE HOSPITAL P. PERRONE, F. MUSCIA, M. CALLONI, M. GUAITA, A. GIORGETTI, P. MANTEGAZZA, G. PATRUNO, L. POLITINI, A. ROMORINI, P. SECCHI, E. VECCHIO (Legnano - MI, Magenta - MI) 129. EPIDEMIOLOGY OF ISCHAEMIC STROKE SUBTYPES P. TOSI, E. BOTTACCHI, G. CORSO, G. GIARDINI, L. CALLIGIANA, C. LIA, M. VERONESE MOROSINI (Aosta) 130. PREDICTORS OF STROKE SEVERITY AND LONG-TERM MORTALITY IN ISCHAEMIC STROKE PATIENTS G. CORSO, E. BOTTACCHI, P. TOSI, G. GIARDINI, C. LIA, L. CALLIGIANA, M. VERONESE MOROSINI (Aosta) 136
131. PREDICTORS OF RECANALIZATION IN ACUTE CEREBRAL INFARCTION FROM OCCLUSION OF THE MIDDLE CEREBRAL ARTERY MAINSTEM TREATED WITH THROMBOLYSIS M. CAMERLINGO, C. ROVARIS, V. TUDOSE, L. PEREGO, M. TOGNOZZI, L. MOSCHINI (Osio Sotto-BG) 132. DOUBLE ANTIAGGREGATION WITH ASPIRIN AND CLOPIDOGREL, WITH OR WITHOUT LOADING DOSE CLOPIDOGREL, FOR EXTRA- AND INTRACRANIAL SYMPTOMATIC STENOSES B. CENSORI, T. PARTZIGUIAN, M. VEDOVELLO, M. POLONI (Bergamo) SCLEROSI MULTIPLA 1 Moderatori L. GRIMALDI (Cefalù - PA) - M.R. ROTTOLI (Bergamo) 133. PREDICTING EARLY CONVERSION TO MULTIPLE SCLEROSIS IN PATIENTS WITH CLINICALLY ISOLATED SYNDROMES: THE IMPORTANCE OF AN INTEGRATED MODELING OF RISK FACTORS V. MARTINELLI, G. DALLA COSTA, B. COLOMBO, G. DI MAGGIO, L. LEOCANI, R. FURLAN, M. FILIPPI, G. COMI (Milano) 134. UNUSUAL SEVERE ADVERSE EVENTS DURING FINGOLIMOD TREATMENT OF MS PATIENTS IN A REAL-WORLD CLINICAL PRACTICE: MERE COINCIDENCE G. PAVAN, M. RODEGHER, L. MOIOLA, F. SANGALLI, M. ROMEO, M. MESSINA, G. COMI, V. MARTINELLI (Milano) 135. SEROPREVALENCE AND SEROCONVERSION OF ANTI-JCV ANTIBODIES IN MULTIPLE SCLEROSIS PATIENTS: DIFFERENT RESULTS BETWEEN FIRST AND SECOND GENERATION OF THE STRATIFY TEST M. CAPOBIANCO, A. LARONI, A. SALA, M. CALDANO, A. UCCELLI, G. MANCARDI, A. BERTOLOTTO (Orbassano - TO, Genova) 136. REDEFINING THE GENETIC ARCHITECTURE OF MULTIPLE SCLEROSIS F. MARTINELLI BONESCHI, S. D’ALFONSO, .. INTERNATIONAL MULTIPLE SCLEROSIS GENETICS CONSORTIUM (IMSGC), .. PROGRESSO CONSORTIUM, .. PROGEMUS CONSORTIUM (Milano, Novara) 137. PREVALENCE OF PAIN IN MULTIPLE SCLEROSIS: A MULTICENTER ITALIAN STUDY C. SOLARO, E. TRABUCCO, M. CELLA, A. SIGNORI, V. MARTINELLI, M. RADAELLI, D. CENTONZE, S. ROSSI, M. GRASSO, A. CLEMENZI, S. BONAVITA, A. D’AMBROSIO, F. PATTI, E. D’AMICO, G. CRUCCU, A. TRUINI (Genova, Milano, Roma, Napoli, Catania) 138. SURFACE EXPANSION OF THE HIPPOCAMPAL DENTATE GYRUS IN MULTIPLE SCLEROSIS: AN IN VIVO EVIDENCE OF NEUROGENESIS G.C. RICCITELLI, M. ROCCA, G. LONGONI, E. PAGANI, B. COLOMBO, M. RODEGHER, A. FALINI, G. COMI, M. FILIPPI (Milano) 139. DYNAMIC PATTERNS OF GRAY AND WHITE MATTER ATROPHY AND MICROSTRUCTURAL TISSUE DAMAGE IN PATIENTS WITH CLINICALLY ISOLATED SYNDROME SUGGESTIVE OF MULTIPLE SCLEROSIS AFTER 2 YEAR FROM THE FIRST CLINICAL EPISODE P. PREZIOSA, M. ROCCA, S. MESAROS, E. PAGANI, D. DAMJANOVIC, T. STOSIC-OPINCAL, J. DRULOVIC, M. FILIPPI (Milano, Belgrado - SRB) 3 N O V E M B R E • A R E A P O S T E R 137
Page 1:
2 5
Page 7 and 8:
Sotto l’Alto Patronato della Pres
Page 9 and 10:
CONSIGLIO DIRETTIVO SIN Presidente
Page 11 and 12:
IN TRENO Stazione Centrale - Stazio
Page 13:
Accademia Nazionale di Medicina 16
Page 16 and 17:
AUDITORIUM SALA SILVER 12.30 - 13.3
Page 18 and 19:
2 N O V E M B R E • S A L A G I A
Page 20 and 21:
2 N O V E M B R E • S A L A CORSO
Page 22 and 23:
Page 24 and 25:
2 N O V E M B R E • CORSO A.N.I.N
Page 26 and 27:
2 N O V E M B R E • S A L A SIMPO
Page 28 and 29:
2 N O V E M B R E • S A L A B L U
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
DOMENICA 3 NOVEMBRE AUDITORIUM SALA
Page 36 and 37:
3 N O V E M B R E • A U D I T O R
Page 38 and 39:
Page 40 and 41:
3 N O V E M B R E • S A L A R O S
Page 42 and 43:
3 N O V E M B R E • COMUNICAZIONI
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
3 N O V E M B R E • S A L A B I A
Page 50 and 51:
3 N O V E M B R E • S A L A RIUNI
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
3 N O V E M B R E • S A L A WORKS
Page 60 and 61:
Page 62 and 63:
3 N O V E M B R E • S A L A WORKS
Page 64 and 65:
Page 66 and 67:
LUNEDI 4 NOVEMBRE AUDITORIUM SALA S
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
4 N O V E M B R E • COMUNICAZIONI
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
4 N O V E M B R E • LETTURA ore 1
Page 86 and 87:
Page 88 and 89: 4 N O V E M B R E • S A L A SIMPO
Page 90 and 91: 4 N O V E M B R E • A U D I T O R
Page 92 and 93: 4 N O V E M B R E • S A L A R O S
Page 94 and 95: 4 N O V E M B R E • S A L A B L U
Page 96 and 97: 4 N O V E M B R E • S A L A WORKS
Page 100 and 101: MARTEDI 5 NOVEMBRE AUDITORIUM SALA
Page 102 and 103: 5 N O V E M B R E • S A L A BREAK
Page 104 and 105: 5 N O V E M B R E • S A L A B I A
Page 106 and 107: 5 N O V E M B R E • S A L A R O S
Page 108 and 109: 5 N O V E M B R E • S A L A B L U
Page 110 and 111: 5 N O V E M B R E • S A L A G I A
Page 114 and 115: 5 N O V E M B R E • S A L A T U R
Page 116 and 117: 5 N O V E M B R E • S A L A TRIAL
Page 124 and 125: 5 N O V E M B R E • S A L A B I A
Page 126 and 127: 5 N O V E M B R E • CHIUSURA DEI
Page 128 and 129: 3 N O V E M B R E • A R E A P O S
Page 152 and 153: 150
Page 188 and 189:
5 N O V E M B R E • A R E A P O S
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
5 N O V E M B R E • A R E A 754.
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
SEGRETERIA IN SEDE CONGRESSUALE La
Page 202 and 203:
ACCREDITAMENTO ECM La Commissione N
Page 204 and 205:
CERTIFICATO ECM Fin quando non era
Page 207 and 208:
Si ringraziano, per l’indispensab
Page 209 and 210:
SI RINGRAZIANO PER LA PARTECIPAZION
Page 212:
SEGRETERIA ORGANIZZATIVA SIN Studio
show all

programma definitivo - SocietÃ italiana di neurologia

Create successful ePaper yourself

Delete template?

Save as template?